Location History:
- Riehen, DE (2013)
- Riehen, CH (2013 - 2023)
Company Filing History:
Years Active: 2013-2025
Title: Christian Kemmer: Innovator in Antibiotic Treatment Methods
Introduction
Christian Kemmer, an accomplished inventor located in Riehen, Switzerland, has made significant contributions to the field of antibiotic treatments. With a portfolio that includes six patents, Kemmer's work primarily focuses on enhancing the efficacy of rifabutin, a critical antibiotic used against infections.
Latest Patents
Kemmer's recent innovations include two notable patents. The first, titled "Rifabutin treatment methods, uses, and compositions," outlines novel systems and methods for improving the clinical effectiveness of rifabutin. His research exploits the discovery of a ferric-coprogen (FhuE) receptor, which plays a vital role in the cellular uptake of rifabutin. The method entails testing patient samples to identify infections and administering a specific formulation of rifabutin that maximizes its pharmacokinetic parameters, specifically achieving a concentration that exceeds 2 mg/L but is below 50 mg/L.
The second patent focuses on "Antibiotic combination therapies," which introduces new treatment strategies utilizing rifabutin in conjunction with other antibiotics, such as colistin and cefiderocol. This approach aims to provide more comprehensive treatment options for patients suffering from various infections.
Career Highlights
Kemmer's career includes notable positions at Bioversys AG and ETH Zurich, where he utilized his expertise to advance research and development in antibiotic treatment solutions. His dedication to improving healthcare through innovative treatments has positioned him as a notable figure in medical technology.
Collaborations
Throughout his career, Kemmer has worked alongside esteemed colleagues like Glenn E. Dale and Sergio Lociuro. These collaborations have further enriched his work, contributing to the shared goal of enhancing the effectiveness of antibiotic therapies.
Conclusion
Christian Kemmer stands out as a significant innovator in the realm of antibiotic treatments, with a focused portfolio of patents aimed at improving patient outcomes. His contributions to the medical field demonstrate a commitment to addressing critical healthcare challenges through innovative methodologies and collaborative efforts.